Expert Review of Vaccines

Papers
(The TQCC of Expert Review of Vaccines is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Impact of the Delta variant on vaccine efficacy and response strategies180
COVID-19 vaccine hesitancy in South Africa: how can we maximize uptake of COVID-19 vaccines?147
Effects of SARS-CoV-2 variants on vaccine efficacy and response strategies133
COVID-19 vaccine: where are we now and where should we go?110
To mix or not to mix? A rapid systematic review of heterologous prime–boost covid-19 vaccination85
DNA vaccines for SARS-CoV-2: toward third-generation vaccination era78
ExploringKlebsiella pneumoniaecapsule polysaccharide proteins to design multiepitope subunit vaccine to fight against pneumonia77
Safety of an inactivated SARS-CoV-2 vaccine among healthcare workers in China63
Nanovaccine: an emerging strategy63
The emergence of new strains of SARS-CoV-2. What does it mean for COVID-19 vaccines?62
COVID-19 vaccine effectiveness among immunocompromised populations: a targeted literature review of real-world studies61
Parental COVID-19 vaccine hesitancy: a cross-sectional survey in Italy56
COVID-19 vaccines: concerns beyond protective efficacy and safety56
Determinants of parental hesitancy to vaccinate their children against COVID-19 in China55
Transmission-Blocking Vaccines: Harnessing Herd Immunity for Malaria Elimination54
Social media strategies to affect vaccine acceptance: a systematic literature review54
Inhaled vaccine delivery in the combat against respiratory viruses: a 2021 overview of recent developments and implications for COVID-1952
Surveying willingness toward SARS-CoV-2 vaccination of healthcare workers in Italy50
Global impact of delta plus variant and vaccination48
COVID-19 vaccination in pregnant and lactating women: a systematic review48
COVID-19 vaccine acceptance and hesitancy among healthcare workers in South Africa48
CpG-Adjuvanted Hepatitis B Vaccine (HEPLISAV-B®) Update47
Willingness to receive a booster dose of inactivated coronavirus disease 2019 vaccine in Taizhou, China41
From COVID-19 Vaccination Intention to Actual Vaccine Uptake: A Longitudinal Study Among Chinese Adults After Six Months of a National Vaccination Campaign41
COVID-19 vaccination hesitancy in pregnant and breastfeeding women and strategies to increase vaccination compliance: a systematic review and meta-analysis37
Vaccine hesitancy in health-care providers in Western countries: a narrative review37
Clinical development and approval of COVID-19 vaccines36
Chlamydia trachomatisvaccines for genital infections: where are we and how far is there to go?36
COVID-19 vaccine equity: a health systems and policy perspective36
Efficacy and effectiveness of a 23-valent polysaccharide vaccine against invasive and noninvasive pneumococcal disease and related outcomes: a review of available evidence36
Microneedle Systems for Vaccine Delivery: the story so far33
From infection to vaccination: reviewing the global burden, history of vaccine development, and recurring challenges in global leishmaniasis protection33
COVID-19 vaccination hesitancy in Italian healthcare workers: a systematic review and meta-analysis32
COVID-19 pandemic: SARS-CoV-2 specific vaccines and challenges, protection via BCG trained immunity, and clinical trials32
Expert review on global real-world vaccine effectiveness against SARS-CoV-232
COVID-19 and vaccination: myths vs science32
Expert review of global real-world data on COVID-19 vaccine booster effectiveness and safety during the omicron-dominant phase of the pandemic31
Thermostable vaccines: an innovative concept in vaccine development31
Inequitable COVID-19 vaccine distribution and the intellectual property rights prolong the pandemic31
The status of human papillomavirus vaccination recommendation, funding, and coverage in WHO Europe countries (2018–2019)30
Vaccine development against Helicobacter pylori: from ideal antigens to the current landscape28
Lifting non-pharmaceutical interventions following the COVID-19 pandemic – the quiet before the storm?27
Herpes zoster and simplex reactivation following COVID-19 vaccination: new insights from a vaccine adverse event reporting system (VAERS) database analysis26
Emerging advances in synthetic cancer nano-vaccines: opportunities and challenges26
Overcoming roadblocks in the development of vaccines for leishmaniasis26
Real-world impact and effectiveness of the quadrivalent HPV vaccine: an updated systematic literature review25
Vaccinomics: a future avenue for vaccine development against emerging pathogens24
Reported adverse effects following COVID-19 vaccination at a tertiary care hospital, focus on cerebral venous sinus thrombosis (CVST)24
A practitioner’s guide to the recombinant zoster vaccine: review of national vaccination recommendations24
Examining the validity of the drivers of COVID-19 vaccination acceptance scale using Rasch analysis24
Correlates of malaria vaccine efficacy24
COVID-19 vaccines and thrombosis with thrombocytopenia syndrome23
Disproportionate COVID-19 vaccine acceptance rate among healthcare professionals on the eve of nationwide vaccine distribution in Bangladesh23
A systematic review of invasive pneumococcal disease vaccine failures and breakthrough with higher-valency pneumococcal conjugate vaccines in children23
SARS-CoV-2 subunit vaccine adjuvants and their signaling pathways23
Overcoming COVID-19 vaccine hesitancy: can Australia reach the last 20 percent?22
Gap between willingness and behavior in the vaccination against influenza, pneumonia, and herpes zoster among Chinese aged 50–69 years22
Progress towards the development of a P. vivax vaccine22
Influenza vaccine: progress in a vaccine that elicits a broad immune response22
Neoantigen-based personalized cancer vaccines: the emergence of precision cancer immunotherapy22
COVID-19 vaccine mandate for healthcare workers in the United States: a social justice policy22
Potential use of convalescent plasma for SARS-CoV-2 prophylaxis and treatment in immunocompromised and vulnerable populations21
Eradicating polio in Pakistan: a systematic review of programs and policies21
Repeated vaccination and ‘vaccine exhaustion’: relevance to the COVID-19 crisis20
Measles, mumps, rubella prevention: how can we do better?20
Multi-functional antibody profiling for malaria vaccine development and evaluation20
Challenges targeting cancer neoantigens in 2021: a systematic literature review20
COVID-19 vaccine design and vaccination strategy for emerging variants20
Equity in vaccination policies to overcome social deprivation as a risk factor for invasive meningococcal disease20
Global prevalence of acceptance of COVID-19 vaccines and associated factors in pregnant women: a systematic review and meta-analysis20
The challenges of a circumsporozoite protein-based malaria vaccine19
Use of lentiviral vectors in vaccination19
Immunization coverage among asplenic patients and strategies to increase vaccination compliance: a systematic review and meta-analysis18
Parental knowledge about respiratory syncytial virus (RSV) and attitudes to infant immunization with monoclonal antibodies18
GMMA as a ‘plug and play’ technology to tackle infectious disease to improve global health: context and perspectives for the future18
Synergistic activity of antibodies in the multicomponent 4CMenB vaccine18
Immunoinformatics-guided designing and in silico analysis of epitope-based polyvalent vaccines against multiple strains of human coronavirus (HCoV)18
Who is more likely to hesitate to accept COVID-19 vaccine: a cross-sectional survey in China17
Seasonal influenza vaccine hesitancy profiles and determinants among Chinese children’s guardians and the elderly17
Comparing reactogenicity of COVID-19 vaccines: a systematic review and meta-analysis17
Recent advances in lipopolysaccharide-based glycoconjugate vaccines17
Non-COVID-19 vaccine hesitancy among migrant populations worldwide: a scoping review of the literature, 2000-202017
Efficacy and safety of influenza vaccination during pregnancy: realizing the potential of maternal influenza immunization16
Vaccine development against methamphetamine drug addiction16
Understanding COVID-19 vaccine acceptance in Pakistan: an echo of previous immunizations or prospect of change?16
Drivers of hesitancy towards recommended childhood vaccines in African settings: a scoping review of literature from Kenya, Malawi and Ethiopia16
Immunoinformatics driven construction of multi-epitope vaccine candidate against Ascaris lumbricoides using its entire immunogenic epitopes15
Estimated global public health and economic impact of COVID-19 vaccines in the pre-omicron era using real-world empirical data15
Vaccination strategies between compulsion and incentives. The Italian Green Pass experience15
The rationale for use of clinically defined outcomes in assessing the impact of pneumococcal conjugate vaccines against pneumonia15
Vaccines against leishmaniasis: using controlled human infection models to accelerate development15
Structural vaccinology of malaria transmission-blocking vaccines15
Recommendations to drive a value-based decision-making on vaccination15
Quantification methods for viruses and virus-like particles applied in biopharmaceutical production processes15
Bacterial biofilm-derived antigens: a new strategy for vaccine development against infectious diseases15
The epidemiologic and biologic basis for classifying older age as a high-risk, immunocompromising condition for pneumococcal vaccine policy15
COVID-19 vaccine coverage, concerns, and preferences among Chinese ICU clinicians: a nationwide online survey15
Monkeypox: a new face of outbreak15
Reactogenicity and immunogenicity of BNT162b2 or mRNA-1273 COVID-19 booster vaccinations after two doses of BNT162b2 among healthcare workers in Japan: a prospective observational study14
The race for a COVID-19 vaccine: where are we up to?14
Why METH users are at high risk of fatality due to COVID-19 infection?14
Evaluating the relationship between myocarditis and mRNA vaccination14
Association of COVID-19 vaccination with herpes zoster: a systematic review and meta-analysis14
Real-world implementation of 4-component meningococcal serogroup B vaccine (4CMenB): implications for clinical practices14
Progress and new horizons toward a VAR2CSA-based placental malaria vaccine14
Immune Response and Safety of Viral Vaccines in Children with Autoimmune Diseases on Immune Modulatory Drug Therapy14
Immunogenicity following revaccination or sequential vaccination with 23-valent pneumococcal polysaccharide vaccine (PPSV23) in older adults and those at increased risk of pneumococcal disease: a revi14
Safety, efficacy, and immunogenicity of the NVX-CoV2373 vaccine13
Ensuring quality and integrity of vaccines throughout the cold chain: the role of temperature monitoring13
Hypothetical emergence of poliovirus in 2020: part 1. Consequences of policy decisions to respond using nonpharmaceutical interventions13
Effectiveness of vaccination against SARS-CoV-2 Omicron variant infection, symptomatic disease, and hospitalization: a systematic review and meta-analysis13
Development of thermostable vaccine adjuvants13
Antibody response to the first dose of AZD1222 vaccine in COVID-19 convalescent and uninfected individuals in Bangladesh13
Advances in SARS-CoV-2 receptor-binding domain-based COVID-19 vaccines13
The next major emergent infectious disease: reflections on vaccine emergency development strategies13
Cardiovascular safety of COVID-19 vaccines in real-world studies: a systematic review and meta-analysis13
Hepatitis E should be a global public health priority: recommendations for improving surveillance and prevention13
Carbohydrate-containing nanoparticles as vaccine adjuvants12
Sporozoite immunization: innovative translational science to support the fight against malaria12
Looking to the future: is a universal coronavirus vaccine feasible?12
Insight into the current Toxoplasma gondii DNA vaccine: a review article12
Delays in routine childhood vaccinations and their relationship with parental vaccine hesitancy: a cross-sectional study in Wuxi, China12
From concept to delivery: a yeast-expressed recombinant protein-based COVID-19 vaccine technology suitable for global access12
Cancer vaccines as a targeted immunotherapy approach for breast cancer: an update of clinical evidence12
Immune to addiction: how immunotherapies can be used to combat methamphetamine addiction12
The baculovirus expression vector system: a modern technology for the future of influenza vaccine manufacturing12
Self-controlled case series design in vaccine safety: a systematic review12
Effects of the COVID-19 pandemic on routine pediatric vaccination in Brazil12
Hypothetical emergence of poliovirus in 2020: part 2. exploration of the potential role of vaccines in control and eradication12
Quadrivalent influenza vaccine (Sinovac Biotech) for seasonal influenza prophylaxis12
0.066892147064209